Dr. Alexander Vaccaro | Biotechnology | Best Researcher Award

Dr. Alexander Vaccaro | Biotechnology | Best Researcher Award

President, Rothman Orthopaedics, United States

Dr. Alexander Richard Vaccaro, M.D., Ph.D., F.A.C.S., is a globally renowned orthopaedic spine surgeon and a pioneer in spinal cord injury research. He serves as the Chairman of Orthopaedics at Sidney Kimmel Medical College at Thomas Jefferson University and the President of the Rothman Institute. With decades of expertise in orthopaedic and neurosurgical advancements, he has played a pivotal role in developing innovative treatments for spinal disorders. His dedication to clinical research, surgical education, and leadership has earned him prestigious awards and global recognition.

Publication Profile

ORCID

🎓 Education

Dr. Vaccaro’s academic journey reflects excellence in medicine, surgery, and business leadership. He graduated Summa Cum Laude in Biology from Boston College (1983), followed by an M.D. from Georgetown University School of Medicine (1987). His surgical internship at Cedars-Sinai Medical Center (1988) and orthopaedic residency at Thomas Jefferson University Hospital (1992) laid the foundation for his career. Further specializing in spine surgery, he completed a Spine Fellowship at the University of California, San Diego (1993). He also earned a Ph.D. from the University of Utrecht, Netherlands (2007) and an MBA from Temple University Fox School of Business (2015), receiving the Dean’s Certificate of Excellence.

💼 Experience

Dr. Vaccaro has over three decades of experience in orthopaedic surgery, neurosurgery, and spinal cord injury treatment. Since 2014, he has been the Chairman of Orthopaedics at Sidney Kimmel Medical College and the Endowed Richard H. Rothman Professor and Chairman of the Department of Orthopaedic Surgery. His long-standing association with Thomas Jefferson University Hospital includes roles as Professor of Orthopaedic Surgery (since 2000) and Professor of Neurosurgery (since 2005). He is also the Co-Director of the Spine Fellowship Program, the Regional Spinal Cord Injury Center of Delaware Valley, and the Reconstructive Spine Service at Rothman Institute. His leadership in spine surgery innovation, education, and research has significantly impacted the field.

🏆 Awards and Honors

Dr. Vaccaro has received numerous prestigious awards for his contributions to spinal surgery and clinical research. Notably, he was the President and Founder of the Association for Collaborative Spine Research (2013). His research excellence has been recognized with the Best Paper Award (2012), the Outstanding Clinical Research Paper (2011), and the Louis A. Goldstein Award for Best Clinical Poster Presentation (2011). His North American Spine Society Top 10 Best Abstracts Award (2011) and multiple international accolades highlight his significant contributions to the field.

🔬 Research Focus

Dr. Vaccaro’s research centers on spinal cord injuries, cervical and lumbar spine disorders, surgical advancements, and spinal biomechanics. His groundbreaking studies have influenced clinical decision-making, surgical techniques, and patient outcomes in orthopaedic and neurosurgical spine treatment. He has led multicenter studies on cervical spondylotic myelopathy, spinal cord trauma, and adjacent segment disease, shaping modern spine surgery practices worldwide.

🔚 Conclusion

Dr. Alexander R. Vaccaro is a visionary leader in spine surgery and orthopaedic research. His exceptional academic background, extensive clinical experience, groundbreaking research, and prestigious accolades make him a trailblazer in spinal cord injury treatment. Through his innovations in spine surgery, mentorship of future surgeons, and relentless pursuit of medical advancements, he continues to transform global spine care and orthopaedic research. 🚀

📖 Publications

Stingers—A Review of Current Understanding and Management – Applied Sciences, 2025 🔗 DOI: 10.3390/app15073510

Epidemiology of Spinal Cord Injury and Associated Mortality, Past and Present. Is There a Difference? – World Neurosurgery, 2024 🔗 DOI: 10.1016/j.wneu.2024.10.009

Cellular Bone Matrix Leading to Disseminated Tuberculosis After Spinal Fusion – JBJS Case Connector, 2023 🔗 DOI: 10.2106/JBJS.CC.23.00047

The Role of Exercise in the Alleviation of Neuropathic Pain Following Traumatic Spinal Cord Injuries: A Systematic Review and Meta-analysis – Neurospine, 2023 🔗 DOI: 10.14245/ns.2346588.294

Complete Versus Incomplete Surgical Resection in Intramedullary Astrocytoma: Systematic Review with Individual Patient Data Meta-Analysis – Global Spine Journal, 2023 🔗 DOI: 10.1177/21925682221094766

Mariana Sánchez | Biotechnology Award | Best Researcher Award

Prof. Dr. Mariana Sánchez | Biotechnology Award | Best Researcher Award

Professor, Metropolitan Autonomous University, Iztapalapa Unit, Mexico

🌟 Mariana Sánchez Ramos is an accomplished biotechnologist and researcher at the Universidad Autónoma Metropolitana Iztapalapa, Mexico. With expertise in plant tissue culture and natural product synthesis, she has significantly contributed to biotechnological innovations. Her research focuses on producing bioactive compounds from medicinal plants, emphasizing their anti-inflammatory, cytotoxic, and antioxidant properties. 🌱🔬

Publication Profile

ORCID

Education

🎓 Mariana holds a Ph.D. in Natural Sciences from the Biotechnology Research Center (CEIB-UAEM), where she studied callus cultures of Ageratina pichinchensis to produce bioactive compounds. She also earned a Master’s degree in Biotechnology (CEIB-UAEM), focusing on characterizing crude lipase from Serratia marcescens, and a Bachelor’s degree in Biochemical Engineering from Instituto Tecnológico de Acapulco, where she conducted a phytochemical study on Lopezia racemosa. 🧪📚

Experience

👩‍🏫 Mariana has served as a Full-time Associate Professor at the Universidad Autónoma Metropolitana Iztapalapa (2022–2024), where she has led research projects on tissue culture and secondary metabolite production. She also worked in R&D at Biokab S.A. de C.V., contributing to the nutraceutical application of arabinoxylans. Her postdoctoral research at UAM Iztapalapa focused on elicited suspension cell cultures of Ageratina pichinchensis. 🌿💡

Research Interests

💡 Mariana’s research revolves around plant tissue culture, secondary metabolite production, and their biopharmaceutical applications. She is particularly interested in studying the anti-inflammatory, antibacterial, cytotoxic, and antioxidant properties of plant-derived compounds, contributing to health and wellness through biotechnology. 🌸🧬

Awards

🏅 Mariana has received recognition for her innovative research in biotechnology, including her contributions to natural product development and plant tissue culture. Her work bridges scientific discovery with practical applications in pharmacology and industrial biotechnology. 🎖️🌍

Publications

Constituents from Ageratina pichinchensis and Their Inhibitory Effect on Nitric Oxide Production
Applied Sciences, 2024. DOI: 10.3390/app14093942.

University Social Responsibility: Bringing Science to Children
International Journal of Human Sciences Research, 2024. DOI: 10.22533/at.ed.5584142416047.

Cytotoxic Activity of Wild Plant and Callus Extracts of Ageratina pichinchensis and 2,3-Dihydrobenzofuran Isolated from a Callus Culture
Pharmaceuticals, 2023. DOI: 10.3390/ph16101400.

In Silico Study Applied to Secondary Metabolites of Ageratina pichinchensis (Asteraceae) for Cancer and Psoriasis
Revista Mexicana de Investigación en Productos Naturales, 2023.

Anti-inflammatory, Antibacterial, and Antioxidant Activity of Leaf and Cell Culture Extracts of Randia aculeata L. and its Chemical Components by GC-MS
South African Journal of Botany, 2022. DOI: 10.1016/j.sajb.2021.08.036.

 

 

Rahul Ingle | Biotechnology | Best Researcher Award

Dr. Rahul Ingle | Biotechnology | Best Researcher Award

Professor, Datta Meghe College of Pharmacy, DMIHER, Wardha, India

Rahul G. Ingle is an accomplished Professor in Pharmaceutical Sciences, renowned for his diverse expertise in drug development, analytical chemistry, and academia. His journey spans from pioneering research in drug analysis at Wockhardt Research Centre to post-doctoral fellowship at Zhejiang University, China, further enhancing his global outlook. Currently, he enriches the academic landscape at Datta Meghe College of Pharmacy, leveraging his extensive research acumen to mentor aspiring pharmacists.

Profile

Google Scholar

Education 🎓

Dr. Ingle’s academic voyage is marked by excellence. He earned his Ph.D. in Pharmaceutical Sciences & Technology from S.R.T.M. University, following distinguished achievements in M. Pharmacy, B. Pharmacy, and D. Pharmacy, nurturing his passion for pharmaceutical chemistry and research.

Experience 💼

With a rich tapestry of professional roles, Dr. Ingle has left an indelible mark in both academia and industry. From his tenure as a Research Scientist at Wockhardt Research Centre to pivotal post-doctoral research in China, he has honed his skills in drug analysis, stability studies, and collaborative research, ensuring compliance with international standards.

Research Interests 🔬

Dr. Ingle’s research portfolio reflects his interdisciplinary approach and commitment to advancing pharmaceutical sciences. He specializes in biopharmaceutical projects, drug stability, and novel drug discovery methodologies, with a particular focus on monoclonal antibodies, nucleic acids, and anticancer agents.

Awards 🏆

Throughout his illustrious career, Dr. Ingle has garnered numerous accolades, including prestigious honors such as MITCON Training Programme, JRF recipient, and Certificate of Merit. His dedication to excellence and scholarly contributions have been recognized both nationally and internationally.

Publications 📖

Application of In Silico Drug Discovery Techniques to Discover a Novel Hit for Target-Specific Inhibition of SARS-CoV-2 Mpro’s Revealed Allosteric binding with MAO-B receptor: A theoretical study to Find a cure for post Covid Neurological disorder – Published in PLOS One, 2023

An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics – Published in Pharmaceutics, 2023

Current development of bioanalytical sample preparation techniques in pharmaceuticals – Published in Journal of Pharmaceutical Analysis, 2022

Freeze-dried monoclonal antibody formulations are unexpectedly more prone to degradation than liquid formulations under shaking stress – Published in Journal of Pharmaceutical Sciences, 2022

Pre-filled dual-chamber devices (DCDs) – Promising high-quality and convenient drug delivery system – Published in International Journal of Pharmaceutics, 2021